LBX Pharmacy Chain JSC banner

LBX Pharmacy Chain JSC
SSE:603883

Watchlist Manager
LBX Pharmacy Chain JSC Logo
LBX Pharmacy Chain JSC
SSE:603883
Watchlist
Price: 14.01 CNY -0.21%
Market Cap: ¥10.6B

EV/S

0.6
Current
27%
Cheaper
vs 3-y average of 0.8

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
0.6
=
Enterprise Value
¥12.1B
/
Revenue
¥22.2B

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
0.6
=
Enterprise Value
¥12.1B
/
Revenue
¥22.2B

Valuation Scenarios

LBX Pharmacy Chain JSC is trading below its 3-year average

If EV/S returns to its 3-Year Average (0.8), the stock would be worth ¥19.14 (37% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+490%
Average Upside
206%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 0.6 ¥14.01
0%
3-Year Average 0.8 ¥19.14
+37%
5-Year Average 1.3 ¥31.96
+128%
Industry Average 1.5 ¥37.75
+169%
Country Average 3.3 ¥82.7
+490%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
¥12.1B
/
Oct 2025
¥22.2B
=
0.6
Current
¥12.1B
/
Dec 2025
¥22.6B
=
0.5
Forward
¥12.1B
/
Dec 2026
¥24.3B
=
0.5
Forward
¥12.1B
/
Dec 2027
¥26.5B
=
0.5
Forward
¥12.1B
/
Dec 2028
¥31.5B
=
0.4
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close

Market Distribution

Lower than 91% of companies in China
Percentile
9th
Based on 7 593 companies
9th percentile
0.6
Low
0 — 1.7
Typical Range
1.7 — 6.2
High
6.2 —
Distribution Statistics
China
Min 0
30th Percentile 1.7
Median 3.3
70th Percentile 6.2
Max 5 034 353.9

LBX Pharmacy Chain JSC
Glance View

Market Cap
10.6B CNY
Industry
Retail

LBX Pharmacy Chain JSC has emerged as a significant player in the pharmaceutical retail sector in China, riding the wave of increasing health consciousness and the aging population. Founded in a fast-paced, constantly evolving market, the company has strategically positioned itself to leverage this demographic shift. Its primary business model revolves around operating an extensive network of pharmacy outlets that serve both urban and rural customers. By offering a wide range of products, from prescription medications to health supplements and wellness goods, LBX ensures it caters to a diverse clientele, satisfying varying health care needs. The implementation of an omnichannel approach, integrating online and offline sales, has not only enhanced customer convenience but also expanded its reach, reinforcing its market position. Central to LBX’s profitability is its efficient supply chain management and strategic location of stores in high-traffic areas, which augments its accessibility and stock management capabilities. The company leverages partnerships with leading pharmaceutical manufacturers and distributors, securing competitive pricing and product availability. Additionally, its investment in technology bolsters its operational efficiency, enabling real-time inventory tracking and personalized customer service. This tech-driven approach enhances customer loyalty and provides insights into consumer behavior, guiding strategic decisions. Through a well-crafted blend of traditional retail expertise and innovative solutions, LBX Pharmacy Chain JSC continues to solidify its foothold in the market, driving revenue growth and expanding its reach across China.

Intrinsic Value
28.63 CNY
Undervaluation 51%
Intrinsic Value
Price ¥14.01
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett